This Month's Tiny Gems - December 2011
Hansen Medical, Inc. (HNSN)
Hansen Medical, Inc., a global leader in flexible robotics, is focused on creating robotic solutions that provide physicians with a better suite of tools for their procedural and therapeutic success. The company's unique combination of technology and ergonomics helps healthcare professionals establish a new standard of care by enabling a new class of percutaneous procedures using advanced electromechanical technology.
Neoprobe Corp. (NEOP)
Neoprobe Corp. has quickly risen to dominate in ILM (intraoperative lymphatic mapping, a minimally invasive lymph node biopsy) cancer surgery markets as the only gamma detection systems developer which simultaneously is refining both its radiotracers and detection hardware. Additionally, the company has a rapidly growing investigational initiative program focused on innovative radiotracing agents and ACT, or activated cellular therapies, under majority-owned subsidiary, Cira Biosciences, Inc.
Ventrus Biosciences, Inc. (VTUS)
Ventrus Biosciences, Inc., a NY-based pharmaceutical developer, while still development stage, has assembled a strong portfolio of product candidates targeting the late-stage prescription market, specifically in the gastrointestinal disorder area. A massive, underserved market of some 12.5M people in the US alone suffer from symptomatic hemorrhoids, with another 7M fecal incontinence and 4M in the anal fissure category, yet no US FDA approved prescription treatments for these conditions appear in the market.